349 related articles for article (PubMed ID: 25370573)
1. Loss of function of SWI/SNF chromatin remodeling genes leads to genome instability of human lung cancer.
Huang HT; Chen SM; Pan LB; Yao J; Ma HT
Oncol Rep; 2015 Jan; 33(1):283-91. PubMed ID: 25370573
[TBL] [Abstract][Full Text] [Related]
2. Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden.
Naito T; Udagawa H; Umemura S; Sakai T; Zenke Y; Kirita K; Matsumoto S; Yoh K; Niho S; Tsuboi M; Ishii G; Goto K
Lung Cancer; 2019 Dec; 138():35-42. PubMed ID: 31630044
[TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
[TBL] [Abstract][Full Text] [Related]
4. Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma.
Manceau G; Letouzé E; Guichard C; Didelot A; Cazes A; Corté H; Fabre E; Pallier K; Imbeaud S; Le Pimpec-Barthes F; Zucman-Rossi J; Laurent-Puig P; Blons H
Int J Cancer; 2013 May; 132(9):2217-21. PubMed ID: 23047306
[TBL] [Abstract][Full Text] [Related]
5. Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer.
Oike T; Ogiwara H; Nakano T; Yokota J; Kohno T
Jpn J Clin Oncol; 2013 Sep; 43(9):849-55. PubMed ID: 23904343
[TBL] [Abstract][Full Text] [Related]
6. Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.
Wilson BG; Helming KC; Wang X; Kim Y; Vazquez F; Jagani Z; Hahn WC; Roberts CW
Mol Cell Biol; 2014 Mar; 34(6):1136-44. PubMed ID: 24421395
[TBL] [Abstract][Full Text] [Related]
7. [Pathological and molecular features of malignancies underlined by BAF complexes inactivation].
Le Quang M; Ranchère-Vince D; Le Loarer F
Ann Pathol; 2019 Dec; 39(6):399-413. PubMed ID: 31255411
[TBL] [Abstract][Full Text] [Related]
8. BAFfling pathologies: Alterations of BAF complexes in cancer.
Arnaud O; Le Loarer F; Tirode F
Cancer Lett; 2018 Apr; 419():266-279. PubMed ID: 29374542
[TBL] [Abstract][Full Text] [Related]
9. The SWI/SNF Complex: A Frequently Mutated Chromatin Remodeling Complex in Cancer.
Nguyen VT; Tessema M; Weissman BE
Cancer Treat Res; 2023; 190():211-244. PubMed ID: 38113003
[TBL] [Abstract][Full Text] [Related]
10. Systematic characterization of BAF mutations provides insights into intracomplex synthetic lethalities in human cancers.
Schick S; Rendeiro AF; Runggatscher K; Ringler A; Boidol B; Hinkel M; Májek P; Vulliard L; Penz T; Parapatics K; Schmidl C; Menche J; Boehmelt G; Petronczki M; Müller AC; Bock C; Kubicek S
Nat Genet; 2019 Sep; 51(9):1399-1410. PubMed ID: 31427792
[TBL] [Abstract][Full Text] [Related]
11. [Chromatin remodeling defects and cancer: the SWI/SNF example].
Bourdeaut F; Bièche I
Bull Cancer; 2012 Dec; 99(12):1133-40. PubMed ID: 23222069
[TBL] [Abstract][Full Text] [Related]
12. Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines.
Medina PP; Romero OA; Kohno T; Montuenga LM; Pio R; Yokota J; Sanchez-Cespedes M
Hum Mutat; 2008 May; 29(5):617-22. PubMed ID: 18386774
[TBL] [Abstract][Full Text] [Related]
13. SMARCA4 and Other SWItch/Sucrose NonFermentable Family Genomic Alterations in NSCLC: Clinicopathologic Characteristics and Outcomes to Immune Checkpoint Inhibition.
Alessi JV; Ricciuti B; Spurr LF; Gupta H; Li YY; Glass C; Nishino M; Cherniack AD; Lindsay J; Sharma B; Felt KD; Rodig SJ; Cheng ML; Sholl LM; Awad MM
J Thorac Oncol; 2021 Jul; 16(7):1176-1187. PubMed ID: 33845210
[TBL] [Abstract][Full Text] [Related]
14. Coffin-Siris syndrome and related disorders involving components of the BAF (mSWI/SNF) complex: historical review and recent advances using next generation sequencing.
Kosho T; Miyake N; Carey JC
Am J Med Genet C Semin Med Genet; 2014 Sep; 166C(3):241-51. PubMed ID: 25169878
[TBL] [Abstract][Full Text] [Related]
15. The SWI/SNF chromatin remodelling complex: Its role in maintaining genome stability and preventing tumourigenesis.
Brownlee PM; Meisenberg C; Downs JA
DNA Repair (Amst); 2015 Aug; 32():127-133. PubMed ID: 25981841
[TBL] [Abstract][Full Text] [Related]
16. Genetic variant in SWI/SNF complexes influences hepatocellular carcinoma risk: a new clue for the contribution of chromatin remodeling in carcinogenesis.
Zhong R; Liu L; Tian Y; Wang Y; Tian J; Zhu BB; Chen W; Qian JM; Zou L; Xiao M; Shen N; Yang H; Lou J; Qiu Q; Ke JT; Lu XH; Wang ZL; Song W; Zhang T; Li H; Wang L; Miao XP
Sci Rep; 2014 Feb; 4():4147. PubMed ID: 24556940
[TBL] [Abstract][Full Text] [Related]
17. Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin.
Stanton BZ; Hodges C; Calarco JP; Braun SM; Ku WL; Kadoch C; Zhao K; Crabtree GR
Nat Genet; 2017 Feb; 49(2):282-288. PubMed ID: 27941795
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on Cancer Therapies including Immunotherapy.
Shi Y; Shin DS
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371564
[TBL] [Abstract][Full Text] [Related]
19. The roles of mutated SWI/SNF complexes in the initiation and development of hepatocellular carcinoma and its regulatory effect on the immune system: A review.
Hu B; Lin JZ; Yang XB; Sang XT
Cell Prolif; 2020 Apr; 53(4):e12791. PubMed ID: 32162380
[TBL] [Abstract][Full Text] [Related]
20.
Concepcion CP; Ma S; LaFave LM; Bhutkar A; Liu M; DeAngelo LP; Kim JY; Del Priore I; Schoenfeld AJ; Miller M; Kartha VK; Westcott PMK; Sánchez-Rivera FJ; Meli K; Gupta M; Bronson RT; Riely GJ; Rekhtman N; Rudin CM; Kim CF; Regev A; Buenrostro JD; Jacks T
Cancer Discov; 2022 Feb; 12(2):562-585. PubMed ID: 34561242
[No Abstract] [Full Text] [Related]
[Next] [New Search]